欧盟HMA药品数据库(European Union HMA Authorisation of Medicines DataBase)
MR编号BE/H/0084/015
药品名称VIRAFERON PEN
活性成分
    • [No Active-Substance specified] 0.0 -
剂型Solution for injection
上市许可持有人N.V.SCHERING-PLOUGH S.A. 73, rue de Stalle 1180 Bruxelles Belgium
参考成员国 - 产品名称Belgium (BE)
互认成员国 - 产品名称
    • Italy (IT)
      INTRON A , PEN, 18 MIU/1.2 ml
    • Greece (GR)
      INTRON A , PEN, 18 MIU/1.2 ml
    • Sweden (SE)
      INTRON A , PEN, 18 MIU/1.2 ml
    • Finland (FI)
      INTRON A , PEN, 18 MIU/1.2 ml
    • Germany (DE)
      INTRON A , PEN, 18 MIU/1.2 ml
    • Denmark (DK)
      INTRON A , PEN, 18 MIU/1.2 ml
    • Netherlands (NL)
      INTRON A , PEN, 18 MIU/1.2 ml
    • Luxembourg (LU)
      Viraferon
    • United Kingdom (Northern Ireland) (XI)
      INTRON A , PEN, 18 MIU/1.2 ml
    • Ireland (IE)
      INTRON A , PEN, 18 MIU/1.2 ml
    • Austria (AT)
      INTRON A , PEN, 18 MIU/1.2 ml
    • France (FR)
      INTRON A , PEN, 18 MIU/1.2 ml
    • Spain (ES)
      INTRON A , PEN, 18 MIU/1.2 ml
    • Portugal (PT)
      INTRON A , PEN, 18 MIU/1.2 ml
许可日期2008/04/05
最近更新日期2020/11/20
药物ATC编码
    • A ALIMENTARY TRACT AND METABOLISM
申请类型
  • TypeLevel1:[not specified]
  • TypeLevel2:[not specified]
  • TypeLevel3:[not specified]
  • TypeLevel4:[not specified]
  • TypeLevel5:[not specified]
附件文件下载
    市场状态Positive
    ©2006-2024 Drugfuture->European Union HMA Authorisation of Medicines DataBase